Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Strategies for the Treatment of HIV Associated Metabolic Syndrome
Brief Summary: A healthy diet and exercise have improved the health of people without human immunodeficiency virus (HIV) who have Metabolic Syndrome. In this study we would like to find out if the same benefit can be seen in people with HIV and Metabolic Syndrome. Patients with Metabolic Syndrome usually have a large waist, high blood cholesterol levels, high blood pressure, and high blood sugar levels. These are risk factors, which may increase one's chance of developing heart disease and/or diabetes. The purpose of the study is to evaluate the effects of different methods of treating HIV associated Metabolic Syndrome. The groups are: 1) a lifestyle modification program plus metformin (also known as glucophage), 2) lifestyle modification plus placebo, 3) metformin alone or 4) placebo alone. The lifestyle modification program consists of nutrition and exercise sessions with the goal of improving body composition, heart health, and ways to lower the risk of developing diabetes.


Options:
A: Arm Label: energy-restricted, CHO-restricted diet; Type: EXPERIMENTAL; Interventions: Other: energy-restricted, CHO-restricted diet | Arm Label: energy-restricted, CHO-rich diet; Type: ACTIVE_COMPARATOR; Interventions: Other: energy-restricted, CHO-rich diet | Intervention Type: OTHER; Name: energy-restricted, CHO-restricted diet; Assigned to Arm(s): energy-restricted, CHO-restricted diet | Intervention Type: OTHER; Name: energy-restricted, CHO-rich diet; Assigned to Arm(s): energy-restricted, CHO-rich diet
B: Arm Label: Group 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Group 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo, Behavioral: Lifestyle Modification | Arm Label: Group 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: Group 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin, Behavioral: Lifestyle Modification | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Group 3, Group 4 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 1, Group 2 | Intervention Type: BEHAVIORAL; Name: Lifestyle Modification; Assigned to Arm(s): Group 2, Group 4
C: Arm Label: Case-Management for Behavior Change; Type: EXPERIMENTAL; Interventions: Behavioral: Vivamos Activos Fair Oaks Program | Arm Label: Case-Management plus Home Visits; Type: EXPERIMENTAL; Interventions: Behavioral: Vivamos Activos Fair Oaks Program | Arm Label: Usual Primary Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Vivamos Activos Fair Oaks Program | Intervention Type: BEHAVIORAL; Name: Vivamos Activos Fair Oaks Program; Assigned to Arm(s): Case-Management for Behavior Change, Case-Management plus Home Visits, Usual Primary Care
D: Arm Label: Ususal Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: Breif Lifestyle Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Lifestyle Counseling | Arm Label: Enhanced Brief Lifestyle Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced Brief Lifestyle Counseling | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Ususal Care | Intervention Type: BEHAVIORAL; Name: Brief Lifestyle Counseling; Assigned to Arm(s): Breif Lifestyle Counseling | Intervention Type: BEHAVIORAL; Name: Enhanced Brief Lifestyle Counseling; Assigned to Arm(s): Enhanced Brief Lifestyle Counseling

Answer: B